Larry Pickering to exec VP from general manager of Ortho's Dermatological Division. A press release on the promotion credits Pickering as "largely responsible for Retin-A's current development as a compound to treat photo-aged skin".
You may also be interested in...
The US green light for Alkindi is a big step for the UK biotech in its bid to become a world-leading specialty endocrinology business.
The agency sees its personnel compensation and benefits costs decrease for the first time in at least 16 years, while the overall FTE count continues to rise.
X-ray manufacturers and importers submitting Electronic Product Control reports will only need to submit their variance application package once.